New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma.
about
Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoidsHuman aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolismStructural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants.Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas.Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesisHigh expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinomaGene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosisTargeting aldose reductase for the treatment of cancerPreparation and characterization of polyclonal antibodies against ARL-1 protein.Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinomaRegulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels.Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesotheliomaExpression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant CancersMetabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis.AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
P2860
Q24294264-E252BDC3-70C1-416F-84D2-6F3337D2915FQ24530114-6A2CABCF-66DB-4898-BB82-C18825CB4CFAQ27649354-5CFE2A75-C495-49CA-B53A-1059252698DAQ30724085-A412B941-7C8F-4E35-85CE-9708DCA12AEAQ33197537-4103A64B-C958-4D18-BF91-F89C2C500743Q33580721-2AC69C41-9C4F-4C15-8F9F-437A77012AA4Q34432183-572E76D2-7ECD-4544-A49D-1375E3FC6626Q34447251-EC108356-AEE3-40F5-90ED-F614FD36E7BFQ35125587-6E866EED-E94F-41BE-99A9-3BD249A1CE78Q36190630-13EC7F4C-AC1A-4840-BA98-B3E90AB5C74CQ36303796-C0BE760C-CBA0-4981-8F69-A12928491D8BQ36629475-DA10AE03-2DBE-4CEC-8FB5-947C34E795ADQ37076019-201CFA99-22A3-43C8-8E9E-ABA39D6B7C60Q37232717-15290CF6-E7F1-4BE2-BEED-3AF4B453B0EAQ37374359-9C1BAB7F-512D-4244-BEA5-51D37C5A7C41Q37446789-A16B5348-4540-4D16-A291-5E01E28535E6Q37623620-C9C90B88-A9D6-43FF-A274-9160F1A792F0Q38524496-795949D6-8748-4039-87FC-F4250A9241D9Q39357739-B5F5BD17-A0E6-462D-A609-A5CEAB9F4463Q40752477-77C737AE-72F7-4571-AEC4-FFF7E9C63983Q41610203-565FD521-F316-43BB-84F0-232F720D7286Q42366521-31B7740D-E363-487A-ACB1-586AEB9AAE88Q42818066-4ABD5016-4CF8-4557-A4B2-3CBD5DA01FB2Q46003997-3B636B2B-9ADE-41F9-B29A-CE66DAE73A5FQ54364816-86AEE3B9-48FC-4C6F-A819-83319A3E65C8
P2860
New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
New member of aldose reductase ...... uman hepatocellular carcinoma.
@ast
New member of aldose reductase ...... uman hepatocellular carcinoma.
@en
New member of aldose reductase ...... uman hepatocellular carcinoma.
@nl
type
label
New member of aldose reductase ...... uman hepatocellular carcinoma.
@ast
New member of aldose reductase ...... uman hepatocellular carcinoma.
@en
New member of aldose reductase ...... uman hepatocellular carcinoma.
@nl
prefLabel
New member of aldose reductase ...... uman hepatocellular carcinoma.
@ast
New member of aldose reductase ...... uman hepatocellular carcinoma.
@en
New member of aldose reductase ...... uman hepatocellular carcinoma.
@nl
P2093
P356
P1433
P1476
New member of aldose reductase ...... uman hepatocellular carcinoma.
@en
P2093
P304
P356
10.1002/HEP.510270408
P407
P577
1998-04-01T00:00:00Z